Go Ahead, Knock Yourself Out: The "Better" Pills
Some prescription sleep options do not wreck your deep sleep at all. They still solve a different problem than the one you actually have.
By Paul Muchowski, Ph.D. — neuroscientist and founder of Defined Sleep
New to the Knock Yourself Out blog series? Start with Part 1 of the series.
Maybe you did the reading, or maybe your doctor did it for you. You are not on the nightcap or the Z-drug. You are on trazodone, or low-dose doxepin, or one of the newer class of sleep drugs called orexin antagonists, and somewhere along the way someone told you this was the good one, the one that does not hollow out your sleep the way the others do. And here is the part I owe you as a scientist, having spent six parts of this series being hard on sedation: on the narrow question of sleep architecture, that person was largely right. Not everything a doctor might prescribe for sleep is a villain, and pretending otherwise would be exactly the kind of overselling this series exists to push back on.
The ones that do not flatten your sleep
A few options genuinely behave differently from alcohol, the Z-drugs, and the benzodiazepines. Trazodone, an older antidepressant used at low doses for sleep, has been shown in a meta-analysis to increase deep slow-wave sleep rather than suppress it. Low-dose doxepin, at the three-to-six-milligram doses approved for insomnia, works as a clean antihistamine at the H1 receptor and, at those doses, appears to preserve normal sleep architecture. Orexin antagonists, such as suvorexant, work by dialing down the brain's wake signal rather than by sedation, and largely leave the architecture of sleep intact, even increasing REM.
So if the only question were "does this drug shrink my deep and REM sleep," these three would pass where the earlier ones fail. Credit where it is due.
The catch each one carries
But architecture is not the only thing that matters, and none of these is free.
Trazodone's alpha-blocking action causes orthostatic hypotension, the blood-pressure drop that leads to dizziness and falls, it brings next-day sedation for a substantial share of users, and, rarely, priapism in men, a genuine medical emergency. Much of its use for sleep is also off-label, with a thinner long-term evidence base than its prescribing volume suggests.
Suvorexant and its class come with their own strange list of side effects, precisely because they act on the wake system: next-day somnolence (sleepiness), and less commonly sleep paralysis, vivid hypnagogic hallucinations, and mild cataplexy-like muscle weakness, along with a dose-dependent signal for worsening mood and suicidal ideation flagged in its labeling. The drug that leaves your sleep stages alone does so by nudging you toward the edge of narcolepsy-like phenomena.
And doxepin is clean only in a narrow window. At the low three-to-six-milligram dose it is well behaved, but it is a tricyclic antidepressant, and at the higher doses often prescribed generically its anticholinergic and cardiac effects return, the same anticholinergic burden that connects, over years of heavy use, to the dementia signal discussed in the Benadryl chapter of this series.
The line that actually matters
Here is the distinction worth leaving you with, because it is the real thesis under all seven parts. The line is not natural versus pharmaceutical. Some of these prescription options are more sophisticated than a nightcap in every way. The line is between a drug that stops you from being awake and an approach that helps you become genuinely rested.
Every one of the "better" pills works by suppressing something: an overactive mind, a histamine signal, the brain's wake drive. Each carries its own tradeoffs. And none of them is designed and demonstrated to actively increase both of the restorative stages, deep slow-wave sleep and REM, at the same time. Preserving your architecture while sedating you is a real improvement over shredding it. It is still not the same as building it.
If you want the sleep, not just the sedation
For some people, in some situations, one of these medications under a doctor's care is the right choice, and nothing in this series is an argument for stopping a prescription on your own. It is an argument for knowing what you are actually buying: relief from wakefulness, with a specific set of costs, rather than a night engineered to leave you more restored than it found you. For chronic insomnia, the first-line treatment remains cognitive behavioral therapy for insomnia, and the foundation under all good sleep remains the unglamorous fundamentals of light, timing, and routine.
That is where the series ends, and where it began. The goal was never to be “knocked out”, or sedated, or even gently switched off with a sophisticated molecule. It was to wake up restored.
Not every pill is a villain. But "does not ruin your sleep" is a low bar, and it is not the same as the thing you actually came here for.
The series: Go Ahead, Knock Yourself Out
-
The Opener — Go Ahead, Knock Yourself Out. Just Don't Call It Sleep.
-
Part 1 — Go Ahead, Knock Yourself Out: Alcohol (The Nightcap)
-
Part 2 — Go Ahead, Knock Yourself Out: Cannabis (The Edible)
-
Part 3 — Go Ahead, Knock Yourself Out: Ambien (The Little Pill)
-
Part 4 — Go Ahead, Knock Yourself Out: Benzodiazepines (The Calm That Costs You)
-
Part 5 — Go Ahead, Knock Yourself Out: Benadryl (The Drugstore Fix)
-
Part 6 — Go Ahead, Knock Yourself Out: Melatonin (The Natural One)
-
Part 7 — Go Ahead, Knock Yourself Out: The "Better" Pills (Not Every Pill Is a Villain) (you are here)
Paul Muchowski, Ph.D. is a neuroscientist, former UCSF professor, and the founder of Defined Sleep. This article is educational and is not medical advice. Do not start or stop any medication without consulting your physician.